Insulin Glargine [rDNA Origin] Injection vs Pioglitazone as add-on Therapy in Patients Failing Monotherapy With Sulfonylurea or Metformin
Clinical trial NCT00384215 · COMPLETED
Trial details
- NCT number
- NCT00384215
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2001-12-01
- Enrollment
- 352
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.